MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
40.97
+6.26 (18.02%)
At close: May 8, 2026, 4:00 PM EDT
41.00
+0.03 (0.09%)
After-hours: May 8, 2026, 7:32 PM EDT
MBX Biosciences Employees
MBX Biosciences had 63 employees as of December 31, 2025. The number of employees increased by 20 or 46.51% compared to the previous year.
Employees
63
Change (1Y)
20
Growth (1Y)
46.51%
Revenue / Employee
n/a
Profits / Employee
-$1,375,698
Market Cap
1.95B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 20 | 46.51% |
| Dec 31, 2024 | 43 | 16 | 59.26% |
| Sep 30, 2024 | 38 | 11 | 40.74% |
| Jun 30, 2024 | 36 | - | - |
| Mar 31, 2024 | 28 | - | - |
| Dec 31, 2023 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Novavax | 749 |
| Immatics | 711 |
| AbCellera Biologics | 562 |
| Immunocore Holdings | 524 |
| Biohaven | 274 |
| Precigen | 160 |
| Maze Therapeutics | 141 |
MBX News
- 2 days ago - MBX Biosciences reports Q1 EPS (51c), consensus (58c) - TheFly
- 2 days ago - MBX Biosciences appoints Mark Soued as chief commercial officer. - TheFly
- 3 days ago - MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 3 days ago - MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award - GlobeNewsWire
- 17 days ago - MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio - GlobeNewsWire
- 5 weeks ago - MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - MBX Biosciences initiated with an Outperform at LifeSci Capital - TheFly
- 6 weeks ago - Options Volatility and Implied Earnings Moves Today, March 23, 2026 - TipRanks